{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:56:31Z","timestamp":1781632591284,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.reumae.2026.502160","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:27:17Z","timestamp":1780486037000},"page":"502160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective effect of methotrexate against severe forms of COVID-19 in rheumatoid arthritis: A retrospective cohort study"],"prefix":"10.1016","volume":"22","author":[{"given":"Freddy","family":"Li\u00f1\u00e1n-Ponce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Leiva-Goicochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gross-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2026.502160_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.reumae.2026.502160_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.35772\/ghm.2023.01024","article-title":"Treatment options for patients with severe COVID-19","volume":"5","author":"Morishita","year":"2023","journal-title":"Glob Health Med"},{"key":"10.1016\/j.reumae.2026.502160_bib0015","series-title":"Computational approaches for novel therapeutic and diagnostic design to mitigate SARS-CoV-2 infection","article-title":"Epidemiology, transmission and pathogenesis of SARS-CoV-2","author":"Sindhuja","year":"2022"},{"key":"10.1016\/j.reumae.2026.502160_bib0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/keac520","article-title":"Dr Yellapragada SubbaRow: the forgotten figure in the history of methotrexate","volume":"62","author":"Bagri","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2026.502160_bib0025","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.reumae.2026.502160_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2026.502160_bib0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/acsptsci.3c00197","article-title":"Methotrexate inhibits the binding of the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) receptor binding domain to the host-cell angiotensin-converting enzyme-2 (ACE-2) receptor","volume":"7","author":"Kim","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.reumae.2026.502160_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101858","article-title":"The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: a systematic review of clinical evidence","volume":"79","author":"Al-Haideri","year":"2023","journal-title":"Transpl Immunol"},{"issue":"9","key":"10.1016\/j.reumae.2026.502160_bib0045","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s12325-023-02533-x","article-title":"Factors associated with severe COVID-19 among patients with rheumatoid arthritis: a large, nationwide electronic health record cohort study in the United States","volume":"40","author":"Ye","year":"2023","journal-title":"Adv Ther [Internet]."},{"key":"10.1016\/j.reumae.2026.502160_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/mr\/roac148","article-title":"Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicentre registry","volume":"34","author":"Boteanu","year":"2023","journal-title":"Mod Rheumatol"},{"issue":"Pt B","key":"10.1016\/j.reumae.2026.502160_bib0055","article-title":"Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic","volume":"101","author":"Ganjei","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.reumae.2026.502160_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198469","article-title":"The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models","volume":"302","author":"Stegmann","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.reumae.2026.502160_bib0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13075-021-02464-4","article-title":"Does methotrexate influence COVID-19 infection? Case series and mechanistic data","volume":"23","author":"Sch\u00e4lter","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2026.502160_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116942","article-title":"Silencing of immune activation with methotrexate in patients with COVID-19","volume":"415","author":"Safavi","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.reumae.2026.502160_bib0075","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jmv.26512","article-title":"Methotrexate inhibits SARS-CoV-2 virus replication in vitro","volume":"93","author":"Caruso","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.reumae.2026.502160_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116935","article-title":"Part II. High-dose methotrexate with leucovorin rescue for severe COVID-19: an immune stabilization strategy for SARS-CoV-2 induced \u201cPANIC\u201d attack","volume":"415","author":"Frohman","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.reumae.2026.502160_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/03009742.2024.2361994","article-title":"Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient","volume":"54","author":"Takatani","year":"2025","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2026.502160_bib0090","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10753-021-01536-6","article-title":"Repurposing Methotrexate in Dampening SARS-CoV2-S1-mediated inflammatory pathways via JAK\/STAT signaling","volume":"45","author":"Gowda","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.reumae.2026.502160_bib0095","article-title":"Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation in vivo and in vitro","volume":"40","author":"Chen","year":"2022","journal-title":"Cell Rep"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:23:46Z","timestamp":1781630626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574326000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2173574326000705"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502160","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of methotrexate against severe forms of COVID-19 in rheumatoid arthritis: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2026.502160","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502160"}}